ALCIDION GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.055 AUD | +1.85% |
|
+22.22% | -26.67% |
| Apr. 18 | Alcidion Logs AU$10 Million Cash Receipts in Fiscal Q3 | MT |
| Apr. 18 | Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Alcidion Group Limited is a healthcare technology company. Its principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Its other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users. The Company services over 400 hospitals.
Sector
Software
Calendar
2024-08-27
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.055
AUD
Average target price
0.08
AUD
Spread / Average Target
+45.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.67% | 48.15M | |
| +8.05% | 3,020B | |
| +5.58% | 82.93B | |
| +3.69% | 76.85B | |
| -14.62% | 53.04B | |
| +31.16% | 50.15B | |
| -24.56% | 46.71B | |
| +17.75% | 41.41B | |
| +55.21% | 36.1B | |
| -10.24% | 24.64B |
- Stock Market
- Equities
- ALC Stock
- News Alcidion Group Limited
- Alcidion Group Extends Partnership with Leidos Australia; Shares Rise 7%
